Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [13558]

Protective drug dexrazoxane reduces heart damage in paediatric cancer survivors years after treatment ends

Protective drug dexrazoxane reduces heart damage in paediatric cancer survivors years after treatment ends

Radiopharmaceutical may benefit patients with metastatic prostate cancer sooner

Radiopharmaceutical may benefit patients with metastatic prostate cancer sooner

Tuft cell-like tumours define an emerging cancer subtype with distinct biology and therapeutic potential

Tuft cell-like tumours define an emerging cancer subtype with distinct biology and therapeutic potential

New insights into FOXK2 reveal expanding role in cancer biology and clinical care

New insights into FOXK2 reveal expanding role in cancer biology and clinical care

Hidden microbial ecosystems inside tumours reveal new frontiers for cancer treatment

Hidden microbial ecosystems inside tumours reveal new frontiers for cancer treatment

Scientists unveil more than 600 new tissue models of human cancer

Scientists unveil more than 600 new tissue models of human cancer

Breakthrough insights into circular RNAs reveal new pathways to reduce cancer treatment toxicity

Breakthrough insights into circular RNAs reveal new pathways to reduce cancer treatment toxicity

New insights into the hidden dialogue between nerves and cancer open pathways for innovative treatments

New insights into the hidden dialogue between nerves and cancer open pathways for innovative treatments

A ‘double-punch’ approach to tackling brain cancer

A ‘double-punch’ approach to tackling brain cancer

Research demonstrates AI-powered target discovery for rare sinonasal cancer

Research demonstrates AI-powered target discovery for rare sinonasal cancer

More from ecancer